Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Hamilton Thorne Ltd T.HTL

Alternate Symbol(s):  HTLZF

Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and... see more

TSX:HTL - Post Discussion

Hamilton Thorne Ltd > earnings thoughts
View:
Post by Possibleidiot01 on May 15, 2023 10:46am

earnings thoughts

I feel good about these especially if you add in the foriegn exchange headwinds (4-5%). In addition ,when the company says 

"Commenting on the Company’s M&A activities, Mr. Wolf stated, “We have an extensive pipeline and are actively working on multiple acquisition opportunities. With significant cash on hand, our unused line of credit, and further debt capacity, we are well positioned to continue to execute on our acquisition program.”

I think we can believe them because they mention expenses on M and A ( last finished acquisition was Microptic - November,2022)  -  "Net income was down, largely due to significant M&A related expenses that we incurred in the quarter.”

A consolidator with good organic growth - "Our organic growth, which eliminates the effects of both acquisitions and exchange rates, was up 15% for the quarter, reflecting continued market share gains.
Comment by dogatcat on May 25, 2023 1:20pm
Overall market malaise has kept the shares down.  This company has a very solid position in the rapidly growing IVF market.   Just keeps growing and consolidating.   IVF is now being added to many company health plans.   I think you are going to see some major growth in this industry and HTL will be riding the wave much higher.      
Comment by dogatcat on Jun 12, 2023 4:14pm
I picked up 10,000 more at $146 today!  Nice little gift as it sold down on relatively small volume.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities